Biocorrx (OTCMKTS:BICX – Get Free Report) and Auna (NYSE:AUNA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability and earnings.
Valuation & Earnings
This table compares Biocorrx and Auna”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Biocorrx | $800,000.00 | 11.13 | -$3.44 million | ($0.16) | -1.88 |
| Auna | $1.23 billion | 0.31 | $27.39 million | $0.26 | 20.00 |
Volatility and Risk
Biocorrx has a beta of 0.17, suggesting that its share price is 83% less volatile than the S&P 500. Comparatively, Auna has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500.
Profitability
This table compares Biocorrx and Auna’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Biocorrx | N/A | N/A | -73.40% |
| Auna | 1.53% | 16.25% | 4.03% |
Analyst Recommendations
This is a summary of recent recommendations for Biocorrx and Auna, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Biocorrx | 0 | 1 | 0 | 0 | 2.00 |
| Auna | 1 | 2 | 1 | 1 | 2.40 |
Auna has a consensus price target of $6.97, indicating a potential upside of 33.97%. Given Auna’s stronger consensus rating and higher possible upside, analysts clearly believe Auna is more favorable than Biocorrx.
Summary
Auna beats Biocorrx on 12 of the 13 factors compared between the two stocks.
About Biocorrx
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
About Auna
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.
Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.
